The health and safety of the PCPV summit registrants is our number one priority. Due to the uncertainty of the impact of COVID-19, we have made the difficult decision to postpone the PCPV Summit to Sept. 14–15th 2022. In the interim, we will be launching a speaker series discussing PV challenges with PCPV Summit speakers and PCPV Board members. Be sure to click Stay Informed below for more updates about the speaker series and PCPV Summit 2022.

Click now to watch our Speaker Series where industry thought leaders discuss solutions to PV Challenges

September 14–15, 2022

Hilton San Francisco Airport Bayfront
600 Airport Blvd.
Burlingame, CA 94010

Hosted by Perspective Pharmacovigilance.
To learn more, click here:

Click now to watch our Speaker Series where industry thought leaders discuss solutions to PV Challenges

September 14–15, 2022

Hilton San Francisco Airport Bayfront
600 Airport Blvd.
Burlingame, CA 94010

Hosted by Perspective Pharmacovigilance.
To learn more, click here:

Click now to watch our Speaker Series where industry thought leaders discuss solutions to PV Challenges

September 14–15, 2022

Hilton San Francisco Airport Bayfront
600 Airport Blvd.
Burlingame, CA 94010

Hosted by Perspective Pharmacovigilance.
To learn more, click here:

About The PCPV Summit 2022

The Pacific Coast Pharmacovigilance (PCPV) Summit endeavors to highlight practical real-world solutions to day to day challenges pharmacovigilance (PV) teams are facing across all therapeutic areas through all stages of development. The PCPV Summit will create an opportunity to foster a PV community on the Pacific Coast. Every year there are numerous PV conferences held on the East Coast or abroad but few on the Pacific Coast that offer practical solutions.

It has been seven years since a conference of this kind was held on the Pacific Coast. The PCPV Team is excited to create a forum in which the PV community can once again come together and cultivate their collective PV knowledge. The Summit will showcase regulators, industry leaders, and PV experts responsible for tackling challenges common within the PV world with real-world examples.

About The PCPV Summit 2022

The Pacific Coast Pharmacovigilance (PCPV) Summit endeavors to highlight practical real-world solutions to day to day challenges pharmacovigilance (PV) teams are facing across all therapeutic areas through all stages of development. The PCPV Summit will create an opportunity to foster a PV community on the Pacific Coast. Every year there are numerous PV conferences held on the East Coast or abroad but few on the Pacific Coast that offer practical solutions.

It has been seven years since a conference of this kind was held on the Pacific Coast. The PCPV Team is excited to create a forum in which the PV community can once again come together and cultivate their collective PV knowledge. The Summit will showcase regulators, industry leaders, and PV experts responsible for tackling challenges common within the PV world with real-world examples.

About The PCPV Summit 2022

The Pacific Coast Pharmacovigilance (PCPV) Summit endeavors to highlight practical real-world solutions to day to day challenges pharmacovigilance (PV) teams are facing across all therapeutic areas through all stages of development. The PCPV Summit will create an opportunity to foster a PV community on the Pacific Coast. Every year there are numerous PV conferences held on the East Coast or abroad but few on the Pacific Coast that offer practical solutions.

It has been seven years since a conference of this kind was held on the Pacific Coast. The PCPV Team is excited to create a forum in which the PV community can once again come together and cultivate their collective PV knowledge. The Summit will showcase regulators, industry leaders, and PV experts responsible for tackling challenges common within the PV world with real-world examples.

Planned Topics

Managing new Technologies in Safety
New EU Clinical Trial Regulations
EU QPPV Perspective: Latest Trends
MHRA and FDA PV Inspection Trends
Impact of Large Data Sources on Benefit Risk Assessments
Development of Novel Medicinal Entities in Combination
Compliant and Scalable Outsourcing in PV
Automation in PV

250

Attendees

10

Speakers

8

Hours of Networking

6

Tutorials

250

Attendees

10

Speakers

8

Hours of Networking

6

Tutorials

250

Attendees

10

Speakers

8

Hours of Networking

6

Tutorials

Targeted Audience

Professionals of all levels in the Pharmaceutical and Biologic Industries, Regulatory Agencies, Government Research and Academic Research Programs, Clinical Research and Contract Service Organizations, and Safety professionals interested in expanding their knowledge and experience in:

  • PV Operations
  • Risk Management
  • Benefit Risk Assessment
  • PV Quality Management Systems
  • PV Inspection Readiness
  • PV Informatics
  • Global PV Regulations
  • PV Outsourcing
  • Use of Technology in PV

Targeted Audience

Professionals of all levels in the Pharmaceutical and Biologic Industries, Regulatory Agencies, Government Research and Academic Research Programs, Clinical Research and Contract Service Organizations, and Safety professionals interested in expanding their knowledge and experience in:

  • PV Operations
  • Risk Management
  • Benefit Risk Assessment
  • PV Quality Management Systems
  • PV Inspection Readiness
  • PV Informatics
  • Global PV Regulations
  • PV Outsourcing
  • Use of Technology in PV

Targeted Audience

Professionals of all levels in the Pharmaceutical and Biologic Industries, Regulatory Agencies, Government Research and Academic Research Programs, Clinical Research and Contract Service Organizations, and Safety professionals interested in expanding their knowledge and experience in:

  • PV Operations
  • Risk Management
  • Benefit Risk Assessment
  • PV Quality Management Systems
  • PV Inspection Readiness
  • PV Informatics
  • Global PV Regulations
  • PV Outsourcing
  • Use of Technology in PV

Speakers

Evan Blander

Vice President, Drug Safety at Exelixis, Inc.

Dr. James Buchanan

President of Covilance, LLC

Shelley Gandhi

Director—Pharmacovigilance and Drug Safety at NDA Group AB

Seema Jaitly

Managing Director and Owner, Essjay Solutions

Stephen Knowles

Chief Medical Officer at Halozyme Therapeutics

Mayur Patel

Vice President, Patient Safety Oncology/ImmunoOncology Therapy at AstraZeneca

Ed Tucker

Chief Medical Officer at Mirum Pharmaceuticals

Bethany Van Veen

CEO and Founder, Perspective Pharmacovigilance, Inc.

Speakers

Evan Blander

Vice President, Drug Safety at Exelixis, Inc.

Dr. James Buchanan

President of Covilance, LLC

Shelley Gandhi

Director—Pharmacovigilance and Drug Safety at NDA Group AB

Seema Jaitly

Managing Director and Owner, Essjay Solutions

Stephen Knowles

Chief Medical Officer at Halozyme Therapeutics

Mayur Patel

Vice President, Patient Safety Oncology/ImmunoOncology Therapy at AstraZeneca

Ed Tucker

Chief Medical Officer at Mirum Pharmaceuticals

Bethany Van Veen

CEO and Founder, Perspective Pharmacovigilance, Inc.

Speakers

Evan Blander

Vice President, Drug Safety at Exelixis, Inc.

Dr. James Buchanan

President of Covilance, LLC

Shelley Gandhi

Director—Pharmacovigilance and Drug Safety at NDA Group AB

Seema Jaitly

Managing Director and Owner, Essjay Solutions

Stephen Knowles

Chief Medical Officer at Halozyme Therapeutics

Mayur Patel

Vice President, Patient Safety Oncology/ImmunoOncology Therapy at AstraZeneca

Ed Tucker

Chief Medical Officer at Mirum Pharmaceuticals

Bethany Van Veen

CEO and Founder, Perspective Pharmacovigilance, Inc.

“West Coast safety professionals and colleagues have been without a local safety-focused conference since the last PDSS meeting years ago. Kudos to Perspective Pharmacovigilance to bring this valuable meeting to the Bay Area where we can connect with our colleagues and learn of the latest safety advances shaping our work all without having to spend two days travel on an airplane.”

– Dr. James Buchanan

“West Coast safety professionals and colleagues have been without a local safety-focused conference since the last PDSS meeting years ago. Kudos to Perspective Pharmacovigilance to bring this valuable meeting to the Bay Area where we can connect with our colleagues and learn of the latest safety advances shaping our work all without having to spend two days travel on an airplane.”

– Dr. James Buchanan

“West Coast safety professionals and colleagues have been without a local safety-focused conference since the last PDSS meeting years ago. Kudos to Perspective Pharmacovigilance to bring this valuable meeting to the Bay Area where we can connect with our colleagues and learn of the latest safety advances shaping our work all without having to spend two days travel on an airplane.”

– Dr. James Buchanan

September 14–15, 2022

Hilton San Francisco Airport Bayfront

September 14–15, 2022

Hilton San Francisco Airport Bayfront

September 14–15, 2022

Hilton San Francisco Airport Bayfront

Focusing on real-world solutions to everyday pharmacovigilance challenges.

September 14–15, 2022

Hilton San Francisco Airport Bayfront
600 Airport Blvd.
Burlingame, CA 94010

Hosted by Perspective Pharmacovigilance.
To learn more, click here:

Focusing on real-world solutions to everyday pharmacovigilance challenges.

September 14–15, 2022

Hilton San Francisco Airport Bayfront
600 Airport Blvd.
Burlingame, CA 94010

Hosted by Perspective Pharmacovigilance.
To learn more, click here:

Focusing on real-world solutions to everyday pharmacovigilance challenges.

September 14–15, 2022

Hilton San Francisco Airport Bayfront
600 Airport Blvd.
Burlingame, CA 94010

Hosted by Perspective Pharmacovigilance.
To learn more, click here: